-
Je něco špatně v tomto záznamu ?
MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study
AI. Tsonis, P. Zisimopoulou, K. Lazaridis, J. Tzartos, E. Matsigkou, V. Zouvelou, R. Mantegazza, C. Antozzi, F. Andreetta, A. Evoli, F. Deymeer, G. Saruhan-Direskeneli, H. Durmus, T. Brenner, A. Vaknin, S. Berrih-Aknin, A. Behin, T. Sharshar, M....
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- autoprotilátky krev MeSH
- dospělí MeSH
- hyperplazie thymu diagnóza MeSH
- lidé středního věku MeSH
- lidé MeSH
- mezinárodní spolupráce MeSH
- myasthenia gravis krev diagnóza patologie MeSH
- neuromyelitis optica diagnóza MeSH
- proteiny související s LDL-receptory imunologie MeSH
- průtoková cytometrie MeSH
- radioimunoanalýza MeSH
- receptory cholinergní imunologie MeSH
- senioři MeSH
- thymus patologie MeSH
- tyrosinkinasové receptory imunologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Seronegative myasthenia gravis (MG) presents a serious gap in MG diagnosis and understanding. We applied a cell based assay (CBA) for the detection of muscle specific kinase (MuSK) antibodies undetectable by radioimmunoassay. We tested 633 triple-seronegative MG patients' sera from 13 countries, detecting 13% as positive. MuSK antibodies were found, at significantly lower frequencies, in 1.9% of healthy controls and 5.1% of other neuroimmune disease patients, including multiple sclerosis and neuromyelitis optica. The clinical data of the newly diagnosed MuSK-MG patients are presented. 27% of ocular seronegative patients were MuSK antibody positive. Moreover, 23% had thymic hyperplasia suggesting that thymic abnormalities are more common than believed.
Bellvitge University Hospital Barcelona Spain
Department of Neurology Medical University of Warsaw Poland
Faculty of Medicine Olso University Norway
Hadassah Hebrew University Medical Center Jerusalem Israel
Hellenic Pasteur Institute Athens Greece
Institute of Neurology Catholic University Rome Italy
Istanbul University Istanbul Turkey
Neurological Institute C Besta Milano Italy
Neurology Clinic Clinical Center of Serbia School of Medicine University of Belgrade Belgrade Serbia
Neurology Department Aeginition Hospital Athens Greece
Norway Department of Neurology Ullevaal University Hospital Oslo Norway
Raymond Poincaré Hospital Garches France
School for Mental Health and Neuroscience Maastricht University The Netherlands
The Cyprus Institute of Neurology and Genetics Nicosia Cyprus
Tzartos NeuroDiagnostics Athens Greece
Universitätsklinikum Halle Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031337
- 003
- CZ-PrNML
- 005
- 20151013122729.0
- 007
- ta
- 008
- 151005s2015 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jneuroim.2015.04.015 $2 doi
- 035 __
- $a (PubMed)26025053
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Tsonis, A I $u Hellenic Pasteur Institute, Athens, Greece; University of Patras, Patras, Greece.
- 245 10
- $a MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study / $c AI. Tsonis, P. Zisimopoulou, K. Lazaridis, J. Tzartos, E. Matsigkou, V. Zouvelou, R. Mantegazza, C. Antozzi, F. Andreetta, A. Evoli, F. Deymeer, G. Saruhan-Direskeneli, H. Durmus, T. Brenner, A. Vaknin, S. Berrih-Aknin, A. Behin, T. Sharshar, M. De Baets, M. Losen, P. Martinez-Martinez, KA. Kleopa, E. Zamba-Papanicolaou, T. Kyriakides, A. Kostera-Pruszczyk, P. Szczudlik, B. Szyluk, D. Lavrnic, I. Basta, S. Peric, C. Tallaksen, A. Maniaol, C. Casasnovas Pons, J. Pitha, M. Jakubíkova, F. Hanisch, SJ. Tzartos,
- 520 9_
- $a Seronegative myasthenia gravis (MG) presents a serious gap in MG diagnosis and understanding. We applied a cell based assay (CBA) for the detection of muscle specific kinase (MuSK) antibodies undetectable by radioimmunoassay. We tested 633 triple-seronegative MG patients' sera from 13 countries, detecting 13% as positive. MuSK antibodies were found, at significantly lower frequencies, in 1.9% of healthy controls and 5.1% of other neuroimmune disease patients, including multiple sclerosis and neuromyelitis optica. The clinical data of the newly diagnosed MuSK-MG patients are presented. 27% of ocular seronegative patients were MuSK antibody positive. Moreover, 23% had thymic hyperplasia suggesting that thymic abnormalities are more common than believed.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a autoprotilátky $x krev $7 D001323
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mezinárodní spolupráce $7 D007391
- 650 _2
- $a proteiny související s LDL-receptory $x imunologie $7 D026502
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a myasthenia gravis $x krev $x diagnóza $x patologie $7 D009157
- 650 _2
- $a neuromyelitis optica $x diagnóza $7 D009471
- 650 _2
- $a radioimunoanalýza $7 D011863
- 650 _2
- $a tyrosinkinasové receptory $x imunologie $7 D020794
- 650 _2
- $a receptory cholinergní $x imunologie $7 D011950
- 650 _2
- $a thymus $x patologie $7 D013950
- 650 _2
- $a hyperplazie thymu $x diagnóza $7 D013952
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zisimopoulou, P $u Hellenic Pasteur Institute, Athens, Greece. Electronic address: zisimopoulou@pasteur.gr.
- 700 1_
- $a Lazaridis, K $u Hellenic Pasteur Institute, Athens, Greece.
- 700 1_
- $a Tzartos, J $u Hellenic Pasteur Institute, Athens, Greece.
- 700 1_
- $a Matsigkou, E $u Hellenic Pasteur Institute, Athens, Greece.
- 700 1_
- $a Zouvelou, V $u Neurology Department, Aeginition Hospital, Athens, Greece.
- 700 1_
- $a Mantegazza, R $u Neurological Institute "C. Besta", Milano, Italy.
- 700 1_
- $a Antozzi, C $u Neurological Institute "C. Besta", Milano, Italy. $7 gn_A_00007581
- 700 1_
- $a Andreetta, F $u Neurological Institute "C. Besta", Milano, Italy. $7 gn_A_00006435
- 700 1_
- $a Evoli, A $u Institute of Neurology, Catholic University, Rome, Italy.
- 700 1_
- $a Deymeer, F $u Istanbul University, Istanbul, Turkey.
- 700 1_
- $a Saruhan-Direskeneli, G $u Istanbul University, Istanbul, Turkey.
- 700 1_
- $a Durmus, H $u Istanbul University, Istanbul, Turkey.
- 700 1_
- $a Brenner, T $u Hadassah Hebrew University Medical Center, Jerusalem, Israel.
- 700 1_
- $a Vaknin, A $u Hadassah Hebrew University Medical Center, Jerusalem, Israel.
- 700 1_
- $a Berrih-Aknin, S $u UPMC and INSERM, Paris, France.
- 700 1_
- $a Behin, A $u UPMC and INSERM, Paris, France.
- 700 1_
- $a Sharshar, T $u Raymond Poincaré Hospital, Garches, France.
- 700 1_
- $a De Baets, M $u School for Mental Health and Neuroscience, Maastricht University, The Netherlands.
- 700 1_
- $a Losen, M $u School for Mental Health and Neuroscience, Maastricht University, The Netherlands.
- 700 1_
- $a Martinez-Martinez, P $u School for Mental Health and Neuroscience, Maastricht University, The Netherlands.
- 700 1_
- $a Kleopa, K A $u The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
- 700 1_
- $a Zamba-Papanicolaou, E $u The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
- 700 1_
- $a Kyriakides, T $u The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
- 700 1_
- $a Kostera-Pruszczyk, A $u Department of Neurology, Medical University of Warsaw, Poland.
- 700 1_
- $a Szczudlik, P $u Department of Neurology, Medical University of Warsaw, Poland.
- 700 1_
- $a Szyluk, B $u Department of Neurology, Medical University of Warsaw, Poland.
- 700 1_
- $a Lavrnic, D $u Neurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia.
- 700 1_
- $a Basta, I $u Neurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia.
- 700 1_
- $a Peric, S $u Neurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia.
- 700 1_
- $a Tallaksen, C $u Norway Department of Neurology, Ullevaal University Hospital, Oslo, Norway; Faculty of Medicine, Olso University, Norway.
- 700 1_
- $a Maniaol, A $u Norway Department of Neurology, Ullevaal University Hospital, Oslo, Norway.
- 700 1_
- $a Casasnovas Pons, C $u Bellvitge University Hospital, Barcelona, Spain.
- 700 1_
- $a Pitha, J $u Department of Neurology and Clinical Neuroscience Center, 1st Faculty of Medicine, Charles University and General Teaching Hospital, Prague, Czech Republic.
- 700 1_
- $a Jakubíkova, M $u Department of Neurology and Clinical Neuroscience Center, 1st Faculty of Medicine, Charles University and General Teaching Hospital, Prague, Czech Republic.
- 700 1_
- $a Hanisch, F $u Universitätsklinikum Halle, Germany.
- 700 1_
- $a Tzartos, S J $u Hellenic Pasteur Institute, Athens, Greece; University of Patras, Patras, Greece; Tzartos NeuroDiagnostics, Athens, Greece. Electronic address: tzartos@pasteur.gr.
- 773 0_
- $w MED00002834 $t Journal of neuroimmunology $x 1872-8421 $g Roč. 284, č. - (2015), s. 10-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26025053 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20151013122918 $b ABA008
- 999 __
- $a ok $b bmc $g 1092213 $s 914463
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 284 $c - $d 10-7 $e 20150427 $i 1872-8421 $m Journal of neuroimmunology $n J Neuroimmunol $x MED00002834
- LZP __
- $a Pubmed-20151005